GlassScriptPhysician profile
Susanna Chan
NPI 1881004059
$2,945.53
in general payments reported to CMS, 2019-2025
27 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $389 · 2021: $450 · 2022: $713 · 2023: $248 · 2024: $252 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $510.77 | 2021-2022 | |
| Smith+Nephew, INC. | $418.38 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $343.70 | 2021-2025 | Nuzyra |
| Tactile Systems Technology INC | $273.85 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bioventus LLC | $251.96 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $208.79 | 2019-2020 | |
| Cardiovascular Systems INC. | $95.65 | 2019 | |
| Amgen INC. | $92.76 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $84.62 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $74.34 | 2020-2023 | Jublia |
| Horizon Therapeutics Plc | $71.91 | 2020-2023 | Krystexxa |
| Abbvie INC. | $59.82 | 2023 | Dalvance |
| Medela LLC | $55.70 | 2020 | |
| Integra Lifesciences Corporation | $45.08 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nabriva Therapeutics, Plc | $44.68 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $43.04 | 2025 | Affinity |
| Vertex Pharmaceuticals Incorporated | $41.82 | 2024 | |
| Kci USA, INC. | $39.22 | 2020-2021 | |
| Reprise Biomedical, INC. | $31.76 | 2024 | Miro3d |
| Solventum Corporation | $30.82 | 2025 | Activ.A.C. |
| Nevro Corp. | $26.13 | 2024 | Senza |
| Orthofix Medical, INC. | $22.75 | 2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $20.14 | 2025 | |
| Merck Sharp & Dohme LLC | $17.21 | 2019 | |
| Djo, LLC | $17.02 | 2020 | |
| Amniox Medical, INC. | $14.25 | 2020 | |
| Bard Peripheral Vascular, INC. | $9.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susanna Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.